Home
ALUR
ALUR News

Latest Allurion Technologies Inc. (ALUR) News on April 3, 2025

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Business Wire

8 days ago

Allurion Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Business Wire

14 days ago

Allurion Announces Initial Results on the Combination of the Allurion Program With Low-dose GLP-1 Therapy to Optimize Muscle Mass and GLP-1 Adherence

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Business Wire

22 days ago

Allurion to Report Fourth Quarter 2024 Financial Results on March 26, 2025

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Business Wire

a month ago

Allurion Announces Notification of Issuance of New U.S. Patents on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion to Participate in Upcoming Investor Conferences

Business Wire

a month ago

Allurion to Participate in Upcoming Investor Conferences

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Business Wire

a month ago

Allurion Announces Closing of Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Business Wire

a month ago

Allurion to Raise Approximately $6.1 Million of Gross Proceeds in Offering and Concurrent Private Placement to Advance GLP-1 Clinical Pipeline

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Business Wire

a month ago

Allurion Announces Plans To Combine GLP-1 Therapy With The Allurion Balloon to Treat Obesity

Allurion Relaunches in France

Business Wire

2 months ago

Allurion Relaunches in France

How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67%

Zacks

2 months ago

How Much Upside is Left in Allurion Technologies, Inc. (ALUR)? Wall Street Analysts Think 374.67%

Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk

Investor's Business Daily

2 months ago

Allurion Catapults 132% On Its Plans To Outdo Eli Lilly, Novo Nordisk

Allurion Stock Skyrockets 80% After Hours Following Clinical Study Announcement

GuruFocus.com

2 months ago

Allurion Stock Skyrockets 80% After Hours Following Clinical Study Announcement

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Business Wire

2 months ago

Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Business Wire

2 months ago

Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Business Wire

2 months ago

Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Business Wire

3 months ago

Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024

Allurion Announces Positive Topline Results From AUDACITY Trial

Business Wire

3 months ago

Allurion Announces Positive Topline Results From AUDACITY Trial

Allurion Technologies, Inc. Announces Reverse Stock Split

Business Wire

3 months ago

Allurion Technologies, Inc. Announces Reverse Stock Split

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next

Yahoo Finance

3 months ago

FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Business Wire

4 months ago

Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance

Allurion launches compounded GLP-1 program as FDA aims to end access

Yahoo Finance

4 months ago

Allurion launches compounded GLP-1 program as FDA aims to end access

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

Business Wire

4 months ago

Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program

Earnings Release: Here's Why Analysts Cut Their Allurion Technologies Inc. (NYSE:ALUR) Price Target To US$1.83

Simply Wall St.

5 months ago

Earnings Release: Here's Why Analysts Cut Their Allurion Technologies Inc. (NYSE:ALUR) Price Target To US$1.83

Allurion Technologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

5 months ago

Allurion Technologies Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Business Wire

5 months ago

Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference

Business Wire

5 months ago

Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Business Wire

5 months ago

Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Business Wire

5 months ago

Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

Business Wire

6 months ago

Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Business Wire

6 months ago

Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss

Allurion Receives Continued Listing Standards Notice from NYSE

Business Wire

7 months ago

Allurion Receives Continued Listing Standards Notice from NYSE

Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity

Business Wire

7 months ago

Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity

Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors

Business Wire

7 months ago

Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors

Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program

Business Wire

7 months ago

Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program

Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial

Business Wire

7 months ago

Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial

Allurion Receives Continued Listing Standards Notice from NYSE

Business Wire

8 months ago

Allurion Receives Continued Listing Standards Notice from NYSE

Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update

Business Wire

8 months ago

Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update

Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Business Wire

9 months ago

Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024

Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement

Business Wire

9 months ago

Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement

Allurion Announces Launch of Offering of Common Stock and Warrants

Business Wire

9 months ago

Allurion Announces Launch of Offering of Common Stock and Warrants

Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss

Business Wire

9 months ago

Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss

Sidoti Events, LLC's Virtual June Small-Cap Conference

ACCESSWIRE

10 months ago

Sidoti Events, LLC's Virtual June Small-Cap Conference

Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Zacks

10 months ago

Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery

Business Wire

10 months ago

Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

10 months ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

10 months ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

10 months ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

10 months ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

10 months ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

10 months ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

10 months ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

10 months ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

10 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

10 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

10 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

10 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

10 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

10 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

10 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

10 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer

Business Wire

10 months ago

Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer

Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s

Business Wire

10 months ago

Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s

Allurion to Participate in Two Upcoming Investor Conferences in June 2024

Business Wire

10 months ago

Allurion to Participate in Two Upcoming Investor Conferences in June 2024

Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss

Business Wire

a year ago

Allurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight Loss

Allurion Reports First Quarter 2024 Financial Results and Provides Business Update

Business Wire

a year ago

Allurion Reports First Quarter 2024 Financial Results and Provides Business Update

Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey

Business Wire

a year ago

Allurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance Survey

Allurion Announces Preliminary First Quarter 2024 Results

Business Wire

a year ago

Allurion Announces Preliminary First Quarter 2024 Results

Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments

Business Wire

a year ago

Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments

Allurion Expands Virtual Care Suite to the United States

Business Wire

a year ago

Allurion Expands Virtual Care Suite to the United States

Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance

Business Wire

a year ago

Allurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance

Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Business Wire

a year ago

Allurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair

Business Wire

a year ago

Milena Alberti-Perez Joins Allurion Board of Directors as Audit Committee Chair

Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024

Business Wire

a year ago

Allurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024

Allurion to Participate in Cowen’s 44th Annual Health Care Conference

Business Wire

a year ago

Allurion to Participate in Cowen’s 44th Annual Health Care Conference

Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Business Wire

a year ago

Allurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Should You Buy OP Bancorp (NASDAQ:OPBK) For Its Upcoming Dividend?

Simply Wall St.

a year ago

Should You Buy OP Bancorp (NASDAQ:OPBK) For Its Upcoming Dividend?

Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies

Business Wire

a year ago

Brendan Gibbons Appointed Chief Legal Officer at Allurion Technologies

European Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques

GlobeNewswire

a year ago

European Parliament’s Environment Committee Votes to Support New Proposal for the Regulation of New Genomic Techniques

Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss

Business Wire

a year ago

Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight Loss

Business Wire

a year ago

Evans Bancorp Announces Fourth Quarter and Full Year 2023 Conference Call and Webcast

Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships

Business Wire

a year ago

Allurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic Partnerships

This Forum Energy Technologies Insider Increased Their Holding By 22% Last Year

Simply Wall St.

a year ago

This Forum Energy Technologies Insider Increased Their Holding By 22% Last Year

Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities

Business Wire

a year ago

Allurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-Morbidities

Everspin Technologies Announces Participation in 26th Annual Needham Growth Conference

Business Wire

a year ago

Everspin Technologies Announces Participation in 26th Annual Needham Growth Conference

Denny's (DENN) Reaches Test Agreement With Franklin Junction

Zacks

a year ago

Denny's (DENN) Reaches Test Agreement With Franklin Junction

7 Overlooked Small-Cap Stocks to Keep On Your Radar

InvestorPlace

a year ago

7 Overlooked Small-Cap Stocks to Keep On Your Radar

Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook

Business Wire

a year ago

Allurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 Outlook

Avanos (AVNS) Preliminary Q4 Revenues Dampened by Lower Sales

Zacks

a year ago

Avanos (AVNS) Preliminary Q4 Revenues Dampened by Lower Sales

New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program

Business Wire

a year ago

New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

GlobeNewswire

a year ago

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

Highland Global Allocation Fund Declares Monthly Distributions of $0.081 Per Share

PR Newswire

a year ago

Highland Global Allocation Fund Declares Monthly Distributions of $0.081 Per Share

RiverNorth Closed-End Funds Declare Monthly Distributions

Business Wire

a year ago

RiverNorth Closed-End Funds Declare Monthly Distributions

Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership

Business Wire

a year ago

Allurion’s Digital Platform Gains Traction with Expanded Strategic Partnership

Seabridge Gold Board Announces Senior Management Changes

Newsfile

a year ago

Seabridge Gold Board Announces Senior Management Changes

Tactile Systems Technology (NASDAQ:TCMD) investors are sitting on a loss of 67% if they invested three years ago

Simply Wall St.

a year ago

Tactile Systems Technology (NASDAQ:TCMD) investors are sitting on a loss of 67% if they invested three years ago

Why You Might Be Interested In Parke Bancorp, Inc. (NASDAQ:PKBK) For Its Upcoming Dividend

Simply Wall St.

a year ago

Why You Might Be Interested In Parke Bancorp, Inc. (NASDAQ:PKBK) For Its Upcoming Dividend

4 Low Price-to-Cash Flow Stocks to Navigate the Market in 2024

Zacks

a year ago

4 Low Price-to-Cash Flow Stocks to Navigate the Market in 2024

Business Wire

a year ago

MFS Releases Closed-End Fund Income Distribution Sources for Certain Funds

Skeena Announces C$10 Million Flow-Through Financing

ACCESSWIRE

a year ago

Skeena Announces C$10 Million Flow-Through Financing

Esperion to Participate in 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

a year ago

Esperion to Participate in 42nd Annual J.P. Morgan Healthcare Conference

Share on Social Networks: